A Visual Tour of Effective Colonoscopy

Slides:



Advertisements
Similar presentations
Tumors of Intestines.
Advertisements

Colorectal Cancer Screening and Surveillance FDA Advisory Committee March, 2002 David Lieberman MD Chief, Division of Gastroenterology Oregon Health Sciences.
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy Supervisor: 邱宗傑 主任 Presented by 郭政裕 總醫師 NEJM, Sep 19, 2013.
The Adenoma/Carcinoma Sequence in the Colon
EQUIP Training session 1
Bowel Preparation Regimens Danielle Goodrich, MSIV University of Maryland School of Medicine.
Surveillance colonoscopy after polypectomy – how frequent? Dr Chu Ming Leong Tuen Mun Hospital 1.
Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD.
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
Colorectal cancer in Norway Maria Mai Ingvild Hvalby.
Update on Colorectal Cancer Screening Tests Source: Levin Bernard et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Benchmarking For Colonoscopy
Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas NICE CG March 2011.
Andreas Adler Charité Medical University of Berlin, Virchow Clinic Campus Central Interdisciplinary Endoscopy Unit Narrow Band versus Conventional Endoscopic.
TREATMENT OF LARGE AND GIANT COLORECTAL POLYPS IN THE REAL WORLD UEGW, PARIS, 2007 Association pour le Dépistage du Cancer colorectal dans le Haut-Rhin.
Colorectal carcinoma Dr.Mohammadzadeh.
CONFIDENTIAL PillCam ™ COLON PillCam™ COLON has received a CE Mark, but is not cleared for marketing or available for commercial distribution in the USA.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Management of Serrated Polyps of Colorectum Eric YF Cheung Department of Surgery, NDH.
Colon polyps Peter Stanich, MD
Evaluation Of Colonic Polyps Kathia E. Rosado Orozco MD GI and Liver Pathologist Hato Rey Pathology Associates.
Serrated Polyps of the Colon Aaron Sinclair, MD University of Kansas School of Medicine – Wichita Department of Family and Community Medicine Wesley Family.
Sessile Serrated Adenomas: A Case Presentation Kevin Witt, PGY3 Justin Whitt, MD IU Health Ball Memorial Family Medicine Residency.
Optical Diagnosis for Colorectal Polyps? Steve Schrock, MD, FAAFP November 5, 2015.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Gastroenterological Society of Queensland Young Investigator Awards The Traditional Serrated Adenoma A Clinicopathological and Molecular Analysis Presented.
R4 채정민 / Prof 이창균. INTRODUCTION colonoscopy is a widely used screening tool for colorectal cancer adenoma detection rate (ADR) important quality indicator.
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
Lynch Syndrome or Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
Comparative Study of Conventional Colonoscopy, Chromoendoscopy, and Narrow-Band Imaging Systems in Differential Diagnosis of Neoplastic and Nonneoplastic.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Clinical process indicators
Quality Indicators for Colonoscopy
Colon Cancer Sreening Recommendations
Colorectal Cancer Screening Guidelines
27th Annual Winter CME Conference
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Irritable Bowel Syndrome
Gastrointestinal Block Pathology lecture 2016/2017
GIT BLOCK PATHOLOGY PRACTICAL Dr Abdullah Basabein
Jasper Vleugels PhD-student AMC
Repeat Colonoscopy Recommendations
Michael Lin, Jenn Hian Koo, David Abi–Hanna 
Improving Quality Measures for Colonoscopy and CRC Prevention
CRC Screening and Quality of Colonoscopy
Feeling Rushed? Does Late Start Time Predict Poor Quality Colonoscopy?
Serrated Colon Polyps as Precursors to Colorectal Cancer
دكترقويدل ژورنال كلاب گوارش. دكترقويدل ژورنال كلاب گوارش.
Surveillance of Dysplasia in Inflammatory Bowel Disease: The Gastroenterologist- Pathologist Partnership  David T. Rubin, Jerrold R. Turner  Clinical Gastroenterology.
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Volume 136, Issue 4, Pages (April 2009)
Nonpolypoid (Flat and Depressed) Colorectal Neoplasms
Polyps of the Colon and Rectum
Endoscopic Management of Nonpolypoid Colorectal Lesions in Colonic IBD
VIRTUAL COLONOSCOPY DR DEEPIKA SOLANKI.
A Visual Tour of Effective Colonoscopy
Volume 140, Issue 7, Pages (June 2011)
Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer  Douglas K. Rex,
Endoscopic Management of Nonpolypoid Colorectal Lesions in Colonic IBD
Erratum Gastrointestinal Endoscopy
Colonic polyps and tumors
Risks of interval colorectal cancer in a FIT-based screening program
Nasim Parsa, MD, Douglas K. Rex, MD  VideoGIE 
Dr. Maha Arafah Dr. Ahmed Al Humaidi
Colonoscopy in crc screening
Hyperplastic polyps and colorectal cancer: is there a link?1
Presentation transcript:

A Visual Tour of Effective Colonoscopy The quality of colonoscopy for colorectal cancer (CRC) screening depends on the operator's ability to detect precancerous lesions (including both conventional adenomas and serrated lesions), remove precancerous lesions effectively, and observe appropriate screening and surveillance intervals. This activity reviews the elements necessary for optimizing CRC screening with colonoscopy.

The quality of colonoscopy for colorectal cancer (CRC) screening depends on the operator's ability to detect precancerous lesions (including both conventional adenomas and serrated lesions), remove precancerous lesions effectively, and observe appropriate screening and surveillance intervals. This activity reviews the elements necessary for optimizing CRC screening with colonoscopy.

New guidelines recommend that colonoscopists be able to achieve adequate preparation in 90% or more of all colonoscopies.[1] Key to increasing rates of effective preparation is to split the dose -- half the preparation is consumed the evening before colonoscopy and half is consumed on the morning of colonoscopy. For afternoon procedures, consuming the entire preparation on the day of colonoscopy is as effective as split dosing. American Society of Anesthesiologists guidelines allow clear liquids to be consumed up until 2 hours before sedation.[2] In split-dose regimens, patients are instructed to drink the second half of the preparation 4 to 6 hours before their procedure is scheduled and to finish by 2 to 3 hours before the scheduled time.

Colonoscopy is less effective at preventing right-sided cancers compared with left-sided colon cancers.[3,4] Less-effective preparation on the right side of the colon may have a role in this discrepancy. Bowel preparation completed the evening before colonoscopy may result in the appearance of the right colon (left image) with adherent chyme and debris in the cecum and ascending colon. A long interval between completion of the preparation and insertion of the colonoscope allows this material to move from the small intestine and adhere to the cecum and ascending colon. Cleaner mucosal surfaces (right image) are seen when a portion of the bowel preparation is given closer to the time of the colonoscopy.

No bowel preparation is ideal for all patients No bowel preparation is ideal for all patients. Low-volume preparations are better tolerated and highly appreciated by patients. They are appropriate for nonconstipated patients who are not receiving agents known to slow bowel motility, such as opioid analgesics. A high-volume preparation such as 4 L of polyethylene glycol-electrolyte lavage solution should be considered in patients who are constipated and in others at higher risk for preparation failure. Some patients will require preparation on 2 consecutive days to achieve effective cleansing.

Approximately two thirds of CRCs arise through the chromosomal instability pathway, are microsatellite stable, have the conventional adenoma (tubular adenoma, tubulovillous adenoma, villous adenoma) as their precursor, and transition through the adenoma-carcinoma sequence slowly, in many cases over an interval of 10 to 15 years.[5] The CpG island methylator phenotype (CIMP) pathway accounts for up to one third of CRCs. The sessile serrated polyp (also known as sessile serrated adenoma) is the primary precursor in this pathway.[5] The least common pathway is the Lynch syndrome, which accounts for 3% of CRCs.[5]

Serrated lesions represent a separate class of precancerous lesions, of which the most important is the sessile serrated polyp (sessile serrated adenoma), the main cancer precursor in the serrated group, with a prevalence of 2% to 4% in screening colonoscopy studies.[5] The serrated class includes hyperplastic polyps, which are common in the rectosigmoid colon, where they appear as small sessile or flat, pale lesions. Hyperplastic polyps have very low malignant potential. The sessile serrated polyp is flat or sessile, can be large, is located primarily in the proximal colon, and shares molecular features with CIMP-positive tumors, including hypermethylation and mutation of the BRAF gene.[5] The traditional serrated adenoma is rare, can be bulky, and is located almost exclusively in the distal colon.[5]

Several studies have highlighted the wide range of detection in patients with adenomas among members of the same gastroenterology groups, which commonly ranges from 3- to 6-fold.[6-9]

Initial studies of the range of detection among members of the same gastroenterology groups for proximal colon serrated lesions (defined here as sessile serrated polyps and hyperplastic polyps proximal to the sigmoid colon) show a greater range than demonstrated in the previously noted studies of variable detection of conventional adenomas.[10,11] This suggests that miss rates for serrated lesions are higher than those seen for conventional adenomas. This observation is consistent with the observation that cancers that occur after a colonoscopy are more likely to be located in the proximal colon, to be CIMP-high, and to be microsatellite unstable.

The subtle shapes taken by precancerous lesions are demonstrated by the Paris classification of precancerous lesion shape, which provides a common vocabulary for discussion of these lesions in the medical literature.[12] Type 1 lesions (polyps) can be either pedunculated (type 1p) or sessile (type 1s). Type 2a and 2b lesions are called “flat.” Type 2a lesions project into the lumen of the gastrointestinal tract but less than the diameter of a standard biopsy forceps (2.5 mm). Type 2b lesions are completely flat and are rare. Type 2c lesions are depressed; they are rare and are associated with a high rate of high-grade dysplasia and invasive cancer.

Skilled detectors must understand and identify a range of precancerous lesions.[13] The top 3 rows represent the conventional adenomas. The more subtle conventional adenomas, including the flat 2a lesions and the depressed 2c lesions, are more prevalent in the proximal colon. The bottom 2 rows represent the precancerous serrated lesions. The sessile serrated polyp is also distributed more toward the right colon. Thus, all of the flat and subtle lesions (Paris type 2) are distributed toward the right colon. These findings emphasize the importance of high-quality bowel preparation and a detailed examination of the proximal colon. Lesions not on the slide that occur commonly are the distal colon hyperplastic polyps, which are considered to have no malignant potential.

These 2 images of flat conventional adenomas emphasize the importance of high-quality bowel preparation and a detailed examination that will allow detection of flat lesions. The examiner should look for subtle changes in color, shape, and texture of the colon surface, as well as interruption of the normal background vascular pattern.

Sessile serrated polyps (left image) typically have a paucity or absence of blood vessels on the surface and sometimes have an adherent mucus cap (not shown). Dark spots across the surface are the typical pits of a serrated lesion. Edges of serrated lesions often are indiscrete, and these lesions often are incompletely resected during colonoscopy. The image at right shows a normal colonic wall vascular pattern toward the top and left direction and loss of the normal vascular pattern in the lower right. Note the slight change in texture of the surface in the lower right. The lower right portion is the edge of a very large, flat sessile serrated polyp.

The left image of a flat sessile serrated polyp has no mucus cap and a few tiny, thin blood vessels. On the right is a lesion with a small amount of debris at the upper left corner and a thin mucus cap over its surface.

The operator's cecal intubation rate and ADR provide data on which to base the quality of colonoscopy. The cecal intubation rate should exceed 95% in screening patients and 90% overall.[14] The ADR (percentage of patients aged 50 years and older undergoing a first screening colonoscopy who have 1 or more adenomas) should exceed 25% in male patients and 15% in female patients. Appropriate use of screening and surveillance intervals is another measure of quality.[14]